Biggest News Aggregation in the World
📰 Analyst More News

Analyst More News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Analyst More. Real-time updates on events, politics, business and more.

Peptide Drug Conjugates Market value of US$ 861.12 Million in 2023 | FMI Study

The global peptide drug conjugates market is expected to be worth US$ 861.12 million in 2023 and US$ 5,331.83 million by 2033. Over the forecast period of 2023 to 2033, the predicted growth rate is about 20%. The growth of the market is attributed to the global upsurge in cancer cases and related mortality, strong c...
United States New York Lutathera Lu Pepaxto Melphalan Asia Pacific Novartis Lutathera

Endocrine Testing Market is anticipated to reach US$ 5735 Million by 2032

The global endocrine testing market is currently valued at US$ 2536.7 Million and is projected to grow at a CAGR of 8.5%. As diabetes cases become more prevalent, the global market is expected to reach a market value of US$ 5735 Million by the year 2032.The growing prevalence of endocrine disorders and the advanceme...
New York United States United Arab Emirates United Kingdom Fiona Pathiraja Rolf Schromgens Trivago

Peptide Drug Conjugates Market is projected to expand at a 20% value CAGR by 2033

The global peptide drug conjugates market is expected to be worth US$ 861.12 million in 2023 and US$ 5,331.83 million by 2033. Over the forecast period of 2023 to 2033, the predicted growth rate is about 20%. The growth of the market is attributed to the global upsurge in cancer cases and related mortality, strong c...
New York United States Innovasium Soricimed Biopharma Lutathera Lu Pepaxto Melphalan Asia Pacific

Oncology Imaging Software Market is expected to reach US$7 Billion by 2033

According to industry experts, the Oncology Imaging Software Market is on the rise and primed for enormous growth. The market is estimated to reach a value pool of US$ 4 billion by the end of 2023, with demand rising at a 5.8% CAGR to US$ 7 billion by 2033.The global oncology imaging software market is expanding sig...
New York United States United Kingdom South Africa New Zealand South Korea

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Whim Syndrome Management Market is expected to reach US$ 17.91 Million by 2033

The global Whim Syndrome Management Market is predicted to generate a market value of US$ 10 million in 2023 and a market value of US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. Between 2018 and 2022, the market for Whim Syndrome Management grew at a CAGR of 4%.The Whim Syndrome Management market is...
United States New York Philip Murphy David Mcdermott Asia Pacific Leadiant Biosciences

Laband Syndrome Therapeutics Market is expected to garner a value of US$ 5 Billion by 2033

A recently published study by FMI expects the global Laband syndrome therapeutics market to augment at a 5.2% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 5 Billion is expected for the market.Rising awareness of rare diseases and increased attention to heredity-related problem...
United States New York Asia Pacific Stelis Biopharma Contract Development Merck Co

Retinal Vein Occlusion Treatment Market expected to reach US$ 4.7 billion by 2033

The global retinal vein occlusion therapy market is predicted to be worth US$ 2.3 billion in 2023, with a compound yearly growth rate (CAGR) of 5.9% to reach US$ 4.7 billion by 2033. Retinal vein occlusion is one of the most common retinal vascular disorders in the elderly, affecting adults over the age of 65. Age i...
New York United States Asia Pacific Regeneron Pharmaceuticals Taiwan Liposome Company Retinal Vein Occlusion Treatment Industry

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science